KR20210046007A - 박테리아 균주를 포함하는 조성물 - Google Patents

박테리아 균주를 포함하는 조성물 Download PDF

Info

Publication number
KR20210046007A
KR20210046007A KR1020217006605A KR20217006605A KR20210046007A KR 20210046007 A KR20210046007 A KR 20210046007A KR 1020217006605 A KR1020217006605 A KR 1020217006605A KR 20217006605 A KR20217006605 A KR 20217006605A KR 20210046007 A KR20210046007 A KR 20210046007A
Authority
KR
South Korea
Prior art keywords
composition
present
strain
mrx0004
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217006605A
Other languages
English (en)
Korean (ko)
Inventor
임케 엘리자베스 멀더
마르실리오 아드리아니
에이미 베스 홀트
마리아 크리스토피
필립 코위
엠마 라프티스
델핀 루이스 클로데트 라우테-칼리
엠마 엘리자베스 클레어 헤네시
수아드 아메드
안나 에토레
Original Assignee
4디 파마 리서치 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1817648.7A external-priority patent/GB201817648D0/en
Priority claimed from GBGB1900335.9A external-priority patent/GB201900335D0/en
Priority claimed from GBGB1901203.8A external-priority patent/GB201901203D0/en
Application filed by 4디 파마 리서치 리미티드 filed Critical 4디 파마 리서치 리미티드
Publication of KR20210046007A publication Critical patent/KR20210046007A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020217006605A 2018-08-17 2019-08-19 박테리아 균주를 포함하는 조성물 Ceased KR20210046007A (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP18189521 2018-08-17
EP18189521.0 2018-08-17
GBGB1817648.7A GB201817648D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GB1817648.7 2018-10-29
GBGB1900335.9A GB201900335D0 (en) 2019-01-10 2019-01-10 Compositions comprising bacterial strains
GB1900335.9 2019-01-10
GB1901203.8 2019-01-29
GBGB1901203.8A GB201901203D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
PCT/EP2019/072181 WO2020035623A1 (en) 2018-08-17 2019-08-19 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
KR20210046007A true KR20210046007A (ko) 2021-04-27

Family

ID=67874412

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217006605A Ceased KR20210046007A (ko) 2018-08-17 2019-08-19 박테리아 균주를 포함하는 조성물

Country Status (14)

Country Link
US (1) US20210330786A1 (https=)
EP (1) EP3836945A1 (https=)
JP (1) JP2021534089A (https=)
KR (1) KR20210046007A (https=)
CN (1) CN113423413A (https=)
AU (1) AU2019322090A1 (https=)
BR (1) BR112021002917A2 (https=)
CA (1) CA3108235A1 (https=)
IL (1) IL280895A (https=)
MA (1) MA53228A (https=)
MX (1) MX2021001888A (https=)
SG (1) SG11202101580TA (https=)
TW (1) TW202023590A (https=)
WO (1) WO2020035623A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195123B (zh) * 2020-10-12 2022-04-29 中科美大(福建)生物科技有限公司 一种植物乳杆菌及其制剂和应用
CN112522248B (zh) * 2020-11-10 2023-10-03 暨南大学 一种包裹型阴沟肠杆菌y16固体菌剂的制备方法及其应用
CN119144528B (zh) * 2024-11-20 2025-06-06 青岛诺和诺康生物科技有限公司 两歧双歧杆菌及其改善哮喘及组胺不耐受的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
CN101595133B (zh) 2006-10-27 2012-11-14 比利时胶囊公司 羟丙基甲基纤维素硬胶囊及制备方法
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
KR101156340B1 (ko) 2009-06-17 2012-06-13 고려대학교 산학협력단 비피도박테리움 브레베 ｌｍｃ５２０ 균주를 이용한 공액리놀렌산의 생산방법
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
AU2015244700B2 (en) * 2014-04-10 2020-08-27 Riken Compositions and methods for induction of Th17 cells
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
NZ737752A (en) * 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
KR102844378B1 (ko) 2016-05-31 2025-08-07 모리나가 뉴교 가부시키가이샤 뇌기능 개선제

Also Published As

Publication number Publication date
CA3108235A1 (en) 2020-02-20
MA53228A (fr) 2021-11-24
WO2020035623A1 (en) 2020-02-20
IL280895A (en) 2021-04-29
SG11202101580TA (en) 2021-03-30
TW202023590A (zh) 2020-07-01
CN113423413A (zh) 2021-09-21
BR112021002917A2 (pt) 2021-05-11
JP2021534089A (ja) 2021-12-09
EP3836945A1 (en) 2021-06-23
AU2019322090A1 (en) 2021-04-15
MX2021001888A (es) 2021-07-16
US20210330786A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
US10987387B2 (en) Compositions comprising bacterial strain
US9974815B2 (en) Compositions comprising bacterial strains
EP3650033B1 (en) Compositions comprising bacterial strains
US20220257745A1 (en) Compositions comprising of bacterial strains
US20230048366A1 (en) Combination therapy for treating or preventing cancer
US20210330786A1 (en) Compositions comprising bacterial strains
KR20250155052A (ko) 장내 미생물총 개체군 조절, 장내 미생물 불균형의 치료 및 질환 예방을 위한 조성물, 및 이의 제조 및 사용 방법
OA20494A (en) Compositions comprising bacterial strains
US20210393773A1 (en) Compositions comprising bacterial strains
WO2023041203A1 (en) Compositions comprising bacterial strains
WO2023041574A1 (en) Compositions comprising bacterial strains
HK40027894A (en) Compositions comprising bacterial strains
HK40027894B (en) Compositions comprising bacterial strains
Schwarzer Impact of Probiotic Bacteria on Allergic Sensitization in Type I Allergy Model

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210304

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220819

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20250403

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20250702

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D